Australia's most trusted
source of pharma news
Posted 1 August 2024 AM
The Federal Government has listed an easy-use version of an emergency medication people have been using off-label, and made the administration of two big name drugs more convenient for patients and health practitioners for some indications.
Clinect's Zyamis is now listed on the PBS to treat Generalised Convulsive Status Epilepticus(SE), after a 2022 PBAC recommendation stalled in negotiations. The company went back to the PBAC last November with some minor changes, which seems to have done the trick.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.